Navigation Links
Revolutionary Immunologic Data Explains Function of Diamyd Diabetes,Vaccine

ing Discovery
“This is the first time it has been demonstrated that stimulating the immune system with an autoantigen, such as GAD65, produces a lasting immunological response, even up to 15 months after the initial vaccination”, stated Anders Essen-Möller, President of Diamyd Medical. ”Moreover, the results are consistent with what is expected according to the prevailing theory of how to treat autoimmune disease. This means that the successful clinical effect of Diamyd® administration is starting to be explained immunologically”.

Presentation of Additional Immunological Data and Type II Study Results
Additional immunological data from the type 1 diabetes study will be presented in the latter part of June at the American Diabetes Association Convention (ADA) in Chicago. Importantly, results from a separate clinical study with the Diamyd vaccine in 160 patients with autoimmune type 2 diabetes (LADA) are also planned to be presented at the same ADA Convention.

Initiation of Phase III Clinical Trials
Diamyd plans to initiate phase III studies in newly onset type 1 diabetics later this year. The US study will take place under the direction of Professor Jerry Palmer, and the Principal Investigator of the European study will be Professor Ludvigsson.

About Diamyd Medical:
Diamyd Medical is a life science company developing treatments for diabetes and its complications. The company’s furthest developed project is the GAD-based drug Diamyd® for autoimmune diabetes. Diamyd® has demonstrated significant and positive results in Phase II clinical trials in both type 1 and autoimmune type 2 diabetes patients (LADA) in Sweden.

GAD65, a major autoantigen in autoimmune diabetes, is the active substance in Diamyd®. GAD65 is also an enzyme that converts the excitatory neurotransmitter glutamate to the inhibitory transmitter GABA. In this context GAD may have an important rol
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Mild Asthma, a Revolutionary Therapy from Italian Research
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
4. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
5. Data Suggest Cymbalta Improved Functioning in Patients with Generalized Anxiety Disorder
6. Early Results of the CellCept Spare the Nephron Study Examine Kidney Function
7. EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
8. Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Brutons Tyrosine Kinase Inhibitors
9. Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of CERE-120 Demonstrating Improved Motor Function in Parkinsons Patients
10. Heart Attack Patients Treated With Novel Stem Cell Therapy Experience Significant Improvement in Heart and Lung Function
11. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
Post Your Comments:
(Date:8/29/2014)... -- , Industry professionals and media ... taking place in real-time at CPhI Worldwide  ... UBM Live , announces the launch of #CPhIChat ... its kind global industry-wide Tweetchat for pharma professionals ... to stimulate conversations on key industry issues and ...
(Date:8/28/2014)... , Aug. 28, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... discover technological and commercial prospects What does ... market? Visiongain,s brand new report shows you ...
(Date:8/28/2014)... -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – ... - http://photos.prnewswire.com/prnh/20140828/140879 ) The ... Poland " an essential source of information and ... and provides insights into the demographic, regulatory, reimbursement ... provides valuable insights into the trends and segmentation ...
Breaking Medicine Technology:CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 2CPhI Worldwide to Host #CPhIChat Provoking Debate on the Future of Pharma 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5
... Md., Oct. 19 Celsion Corporation (Nasdaq: ... on the ThermoDox® High Intensity Focused Ultrasound (HIFU) ... at the MR-guided Focused Ultrasound 2010 2nd International ... as well as the rationale and support for ...
... 19 BioMolecular Therapeutics, Inc. (BMT, Inc.), a ... technology designed to reduce significantly deleterious side effects ... launched its global operations. The company is currently ... degeneration (AMD), based on its asymmetric shorter-duplex siRNA ...
Cached Medicine Technology:Celsion Announces ThermoDox's Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium 2Celsion Announces ThermoDox's Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium 3BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors 2BioMolecular Therapeutics, a New Global Player in RNAi Therapeutics, Launches Company and Adds Key Advisors 3
(Date:8/29/2014)... 2014 For the fifth year in ... will be observing September 26th as Mesothelioma Awareness Day, ... New York. , Members of the community who ... The Foundation will be providing t-shirts and signs to ... community members have received attention from Al Roker ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Empty ... Today at http://www.blogtalkradio.com/dr-carol-francis/2014/08/29/psychologist-dr-carol-francis-addressing-empty-nest-syndrome .     , Mothers and ... of money, marital bliss, prodding, laughing and sweating ... the house this week. Relief and parenting ... “now what.” Dr. Carol Francis as ...
(Date:8/29/2014)... TX (PRWEB) August 29, 2014 PreDiabetes ... off the fall season by offering Web shoppers a 20% ... PreD Store , the Company’s online healthy living shop, beginning ... should be top priority when heading into the chilly fall ... lifestyle habits. During this season, people usually ditch the healthy ...
(Date:8/29/2014)... 2014 TayganPoint Consulting Group, a leading ... second time, Inc. Magazine has named the company one ... Based on solid revenue growth of over 166% over ... on the list. TayganPoint’s repeat success in this ... past few years, is a demonstration of its strong ...
(Date:8/29/2014)... Innovations Television, produced by DMG Productions, announced ... Innovations, focusing on health and elderly care, slated to air ... of Americans over 65 will nearly double by 2030, expanding ... 2030, for a total of 72 million people. Though many ... at least one chronic condition and use healthcare services more ...
Breaking Medicine News(10 mins):Health News:Organization to Raise Awareness of Mesothelioma on the Today Show 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 3Health News:PreDiabetes Centers Online Store Launches Fall Savings Event 2Health News:Innovations with Ed Begley, Jr., Seeking Content for Upcoming Series on Health and Elder Care 2
... million Americans currently live near temporary nuclear waste storage ... ... A Minnesota Indian tribe is,again echoing the need for a national ... facility at,Yucca Mountain. High-level, radioactive nuclear waste from the nation,s,nuclear power plants ...
... Quickly as Governor Ritter Signs Bill Amending Colorado,s ... ... millions,of dollars with the availability of a wide range of $4 ... Wal-Mart,to expand the number of $4 prescriptions available to Colorado citizens.,Wal-Mart ...
... pain, a leading cause of disability and employee absenteeism, ... , A review of recent studies on pain medicine ... of General Internal Medicine reports that while various approaches ... and disadvantages, researchers don,t yet know how to determine ...
... alcohol, study finds , , THURSDAY, June 5 (HealthDay News) ... risk of smoking and substance abuse, says a Massachusetts ... "This work confirms that bipolar disorder in adolescents is ... as big a risk factor as juvenile delinquency," study ...
... at Harvard University have modeled in the laboratory a primitive ... containing DNA. , Since there are no physical records ... or how they grew and divided, the research team,s protocell ... earliest cells may have interacted with their environment approximately 3.5 ...
... Inc. (Nasdaq: ALXN ) today announced that Dr. ... at the,Goldman Sachs 29th Annual Global Healthcare Conference in ... eastern) on Thursday, June 12, 2008., An audio ... You can,access the webcast at: http://www.alexionpharm.com . ...
Cached Medicine News:Health News:DOE Seeks Licensing Approval for Yucca Mountain Nuclear Waste Storage Site 2Health News:Wal-Mart Expands $4 Prescription List in Colorado 2Health News:How best to treat chronic pain? The jury is still out 2Health News:Bipolar Teens at Greater Risk of Substance Abuse 2Health News:A new way to think about Earth's first cells 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: